Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGOSTO:IMP A SDB +0.32%25 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates OSTO:IMP A SDB with a GF Score™ of 25/100. Among 815 Medical Devices & Instruments companies, Implantica AG ranks worse than 122699.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Implantica AG's EBITDA for the
six
months ended in . 20 was kr0.00 Mil. Implantica AG's Revenue for the
six
months ended in . 20 was kr0.00 Mil. Therefore, Implantica AG's EBITDA margin for the quarter that ended in . 20 was 0.00%.
Implantica AG (OSTO:IMP A SDB) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Implantica AG EBITDA Margin % Related Terms
Implantica AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Implantica AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG EBITDA Margin % Chart
Implantica AG Annual Data
Trend
EBITDA Margin %
Implantica AG Semi-Annual Data
EBITDA Margin %
OSTO:IMP A SDB vs : EBITDA Margin % Comparison
For the Medical Devices subindustry, Implantica AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Implantica AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (OSTO:IMP A SDB) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Implantica AG's EBITDA Margin % too high?
Implantica AG's current EBITDA Margin % is 0.00%. Based on the distribution chart, Implantica AG ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's EBITDA Margin % compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 815 companies for EBITDA Margin %. This places Implantica AG in the lower half of its industry. The industry median EBITDA Margin % is 7.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (OSTO:IMP A SDB) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Implantica AG's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Implantica AG (OSTO:IMP A SDB), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
25GF Score
Get the complete analysis for OSTO:IMP A SDB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:IMP A SDB has been successfully added to your 
